Skip to content

Use of Tablet Recure G with Gokshura Kwath in the patients of Chronic Kidney Disease

An Exploratory Study To Evaluate The Combined Effect of Tablet Recure G Kalpita Yoga with Gokshura Kwath in the Management of Mutraghata W S R to Chronic Kidney Disease - nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/086118
Enrollment
30
Registered
2025-05-01
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)

Interventions

None listed

Sponsors

Post Graduate Institute Of Ayurved Jodhpur Rajastan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patient between the Age group of 18 to 70 years Patient of either sex Cases will be taken if any symptoms of any kind of mutraghata are present Patients with GFR level more than 30 ml per min Higher than normal levels of creatinine or urea in the blood Blood urea less than 150mg per dl Serum creatinine less than 5 mg per dl Patients who are willing to sign written consent will be included Patient should be capable of obeying Pathya apathya

Exclusion criteria

Exclusion criteria: Age less than 18 years and more than 70 years Female patients having pregnancy breast feeding or post delivery period Patients who are on dialysis treatment for more than 12 months period Patients who are already operated for renal transplantation and then having nephropathy Patients with some serious illness like cardio vascular diseases acute mental disorders serious acute organic diseases metabolic acidosis hypo or hyper thyroidism other kidney liver or metabolic disorders etc Patients with congenital renal anomalies obstructive uropathy and tumors of the kidney GFR level below than 30ml per min Blood urea more than 150mg per dl Serum creatinine more than 5 mg per dl Patients having very high level of blood sugar

Design outcomes

Primary

MeasureTime frame
To assessment of Subjective and Objective parameters before and after TreatmentTimepoint: 60 days

Secondary

MeasureTime frame
To Observe Any side Effects If occur During Clinical TrialTimepoint: 60 days

Countries

India

Contacts

Public ContactDr Brahmanand Sharma

Post Graduate Institute Of Ayurved Jodhpur,Rajastan

sirawag.vikram7@gmail.com9518438426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026